Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization
about
Measurement Error and Environmental Epidemiology: A Policy PerspectiveObservational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.Rationale and design of the European Polyp Surveillance (EPoS) trials.Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators.Statins and breast cancer prognosis: evidence and opportunities.The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death.Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapyWhy post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials.Causal effects of time-dependent treatments in older patients with non-small cell lung cancer.Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up studyMultiple Imputation to Account for Measurement Error in Marginal Structural ModelsPrognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience.Beyond the intention-to-treat in comparative effectiveness research.Randomized trials analyzed as observational studies.Sex hormone therapy and progression of cardiovascular disease in menopausal womenIs the large simple trial design used for comparative, post-approval safety research? A review of a clinical trials registry and the published literature.Comments on Lauer's 'How the debate about comparative effectiveness research should impact the future of clinical trials'.Methodologic Issues When Estimating Risks in Pharmacoepidemiology.Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.Application of causal inference methods in the analyses of randomised controlled trials: a systematic review.Application of the Marginal Structural Model to Account for Suboptimal Adherence in a Randomized Controlled Trial.An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use.Improved adherence adjustment in the Coronary Drug Project.
P2860
Q29248055-443D0523-CE10-4745-9068-9EE2CDF48A72Q30538243-1DF4312B-BC08-4BBA-B346-35F47EC83926Q30696956-5731B078-0B90-478B-A052-258B179E9B5BQ33625634-E54B21D3-4268-4067-BE0D-3752C08882B8Q33882803-8B3CF66B-5A8A-4704-859C-86E66585EBC3Q34206487-CA1D06E6-BCDA-450E-9674-5450C1208A4BQ34229301-E10A3C3A-7BB6-4CA8-9712-D5C6B1DC4A05Q35076584-3108BDD3-6E79-4192-B9B7-DD21EEDFDB69Q35164187-98B172EA-A9E5-4D0A-B6E0-BF83620CA3F5Q35302530-DE5DF37E-0E2E-4FB8-9405-123C0CED29E4Q35470434-99EB5BC4-2F74-4B9B-92A9-880F467F5437Q36263315-55BAAA82-E8C2-4571-B4F3-DC2334B29160Q36399592-47EA290D-65C6-49C3-AEF8-B438EE28E95EQ37063507-42F7DBD2-4105-43A4-8BC5-F1BE4DD26209Q37387434-E5BA24D6-A515-4A96-96C3-2E13F1724208Q37651567-2E88553F-6CD4-4796-B69F-A494A1C6D463Q37924275-BA2B43C2-2667-4F4C-BC92-24B544D3D9B5Q39538490-5EC4369A-8516-4012-9135-60DA6F2CA5EDQ40077021-32E7A685-1E52-4210-B94F-4B72499F7269Q40305276-069DBC82-65E4-4318-915B-18A2C85D6EFFQ47369859-14D01FB4-D9AC-47A6-B841-F4DFBFBC614EQ47557200-3D835118-895E-421B-9060-C7BE117EBF8EQ51036797-F2D69380-0489-43E0-940E-090841616D4AQ54258926-F76BAC99-0685-42C0-9037-6ACCBB35092CQ55019697-B02A147F-0A5D-44DC-9F3B-74E6504360F6
P2860
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Estimating absolute risks in t ...... dy with baseline randomization
@ast
Estimating absolute risks in t ...... dy with baseline randomization
@en
type
label
Estimating absolute risks in t ...... dy with baseline randomization
@ast
Estimating absolute risks in t ...... dy with baseline randomization
@en
prefLabel
Estimating absolute risks in t ...... dy with baseline randomization
@ast
Estimating absolute risks in t ...... dy with baseline randomization
@en
P2093
P2860
P1433
P1476
Estimating absolute risks in t ...... dy with baseline randomization
@en
P2093
James M Robins
Miguel A Hernán
Roger Logan
Sengwee Toh
Sonia Hernández-Díaz
P2860
P304
P356
10.1097/EDE.0B013E3181DF1B69
P577
2010-07-01T00:00:00Z